Position history for CONGRESS ASSET MANAGEMENT CO's holdings in LIGAND PHARMACEUTICALS INC
CONGRESS ASSET MANAGEMENT CO holds 504,637 shares of LGND (LIGAND PHARMACEUTICALS INC), worth $100.8M as of 2026-Q1. The position was increased (+5.1% shares). LGND represents 0.7% of CONGRESS ASSET MANAGEMENT CO's portfolio.
Current Value
$100.8M
Current Shares
504,637
Total Value Change
+$51.3M
Total Shares Change
-81,987
Other major holders of LGND: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 504,637 |
+5.1% |
| $100.8M |
| 0.7% |
| $204.24 |
44 |
| 2025-Q4 | Decreased | 480,063 | -28.1% | $90.8M | 0.6% | $190.20 | 0 |
| 2025-Q3 | Increased | 667,311 | +3.0% | $118.2M | 0.8% | $173.13 | 44 |
| 2025-Q2 | Increased | 647,941 | +0.8% | $73.7M | 0.5% | $114.15 | 42 |
| 2025-Q1 | Increased | 642,712 | +3.4% | $67.6M | 0.5% | $107.62 | 43 |
| 2024-Q4 | Increased | 621,482 | +2.9% | $66.6M | 0.5% | $105.76 | 36 |
| 2024-Q3 | Increased | 604,038 | +3.0% | $60.5M | 0.4% | $97.37 | 36 |
| 2024-Q2 | New | 586,624 | - | $49.4M | 0.4% | $84.26 | 48 |